These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6300133)
21. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014 [TBL] [Abstract][Full Text] [Related]
22. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
23. Decreased calcium dependence of lymphoblastoid cell lines compared with Burkitt lymphoma cell lines. Parsons PG; Moss DJ; Morris C; Musk P; Maynard K; Partridge R Int J Cancer; 1985 Jun; 35(6):743-7. PubMed ID: 2989188 [TBL] [Abstract][Full Text] [Related]
24. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line. Cuomo L; Ramquist T; Trivedi P; Wang F; Klein G; Masucci MG Int J Cancer; 1992 Jul; 51(6):949-55. PubMed ID: 1322379 [TBL] [Abstract][Full Text] [Related]
25. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines. Szekely L; Pokrovskaja K; Klein G Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911 [TBL] [Abstract][Full Text] [Related]
26. Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid lines. Wennborg AD; Altiok E; Moore JP; Ernberg I; Klein G Eur J Cancer; 1991; 27(12):1643-5. PubMed ID: 1782076 [TBL] [Abstract][Full Text] [Related]
27. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines. Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865 [TBL] [Abstract][Full Text] [Related]
28. Cell surface glycoprotein changes in Epstein-Barr virus-positive and -negative human hematopoietic cell lines. van Beek WP; Nilsson K; Klein G; Emmelot P Int J Cancer; 1979 Apr; 23(4):464-73. PubMed ID: 220199 [TBL] [Abstract][Full Text] [Related]
29. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines. Stoerker J; Yajima Y; Glaser R Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115 [TBL] [Abstract][Full Text] [Related]
30. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237 [TBL] [Abstract][Full Text] [Related]
31. Circular Epstein-Barr virus genomes of reduced size in a human lymphoid cell line of infectious mononucleosis origin. Adams A; Bjursell G; Kaschka-Dierich C; Lindahl T J Virol; 1977 May; 22(2):373-80. PubMed ID: 194059 [TBL] [Abstract][Full Text] [Related]
32. Chromosome #14 markers in two Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines of normal origin differ from the Burkitt lymphoma (BL)-associated 14q+ marker. Manolov G; Manolova Y; Klein G; Levan A; Kieler J Cancer Genet Cytogenet; 1981 Oct; 4(2):179-84. PubMed ID: 6277469 [TBL] [Abstract][Full Text] [Related]
33. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Klein G; Klein E; Kashuba E Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113 [TBL] [Abstract][Full Text] [Related]
34. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines. Steel CM; Morten JE; Foster E IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993 [TBL] [Abstract][Full Text] [Related]
35. Establishment of EBV-Infected Lymphoblastoid Cell Lines. Nagy N Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266 [TBL] [Abstract][Full Text] [Related]
36. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus. Gregory CD; Edwards CF; Milner A; Wiels J; Lipinski M; Rowe M; Tursz T; Rickinson AB Int J Cancer; 1988 Aug; 42(2):213-20. PubMed ID: 2841246 [TBL] [Abstract][Full Text] [Related]
37. An identification of a transforming region of Epstein-Barr viral DNA cannot be confirmed. Miller G; Sugden B Virology; 1985 Jun; 143(2):478-84. PubMed ID: 2998023 [TBL] [Abstract][Full Text] [Related]
38. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047 [TBL] [Abstract][Full Text] [Related]
39. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333 [TBL] [Abstract][Full Text] [Related]
40. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. Freund GG; Kulas DT; Way BA; Mooney RA Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]